Biotechnology & Trade Secret Protection
By Sharon Roberg-Perez, and David Prange
July 15, 2021
In the biotechnology industry, the high cost of technology innovation and bringing products to market necessitates broadening the impact of research investments. Collaboration to develop the next nascent technology presents ownership risks to the developed intellectual property, particularly when a partnership sours or employees perceive better opportunities elsewhere.
In such a situation, these new technologies and their embodied intellectual property, particularly trade secrets, could be quickly lost along with the expected market advantage. The remaining option in many cases is litigation, which is an imperfect solution to correcting the lost market opportunity. But proactive measures can either deter intellectual property theft or improve odds in litigation. This article identifies three lessons learned from recent disputes to help companies improve their intellectual property protection.
The articles on our website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice. The views and opinions expressed in this article are those of the author(s) and do not necessarily reflect the views or official position of Robins Kaplan LLP.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.